Lewis Grossman is a professor at Washington College of Law at American University in Washington, D.C., and co-author of Food and Drug Law: Cases and Materials, 3rd ed. (Foundation Press, 2007). His interests include civil procedure, food and drug law and legal history. He is of counsel at the law firm of Covington & Burling.

Frances Miller is a professor of law emerita at Boston University School of Law. Her interests include health law, food and drug law, biotechnology and genetics, comparative health systems, competition vs. regulation in health care and trusts and estates.

Mary Ann Chirba is a professor of legal reasoning, research & writing at the Boston College Law School in Newton, Mass.

U.S. Food and Drug Administration (FDA) resource about the development and approval of new drugs.

Dec. 18, 2006, The New Yorker article by Dr. Jerome Groopman about the Abigail Alliance case.

Dr. Sidney Wolfe is a senior adviser and co-founder of the Health Research Group, one of Public Citizen’s five policy groups. Public Citizen is a nonprofit public interest group in Washington, D.C. Contact Angela Bradbery, director of communications.

Kenneth Kaitin is director of the Tufts Center for the Study of Drug Development in Boston.

Scott Ballenger is founder of the Trial Acceleration Institute in Spring House, Pa., which assists stakeholders in speeding up clinical trials.

Frank Palumbo is a professor and director of the Center on Drugs and Public Policy at the University of Maryland School of Pharmacy in Baltimore.